nodes	percent_of_prediction	percent_of_DWPC	metapath
Afatinib—Vandetanib—AXL—refractive error	0.0575	1	CrCbGaD
Afatinib—EGFR—DAP12 interactions—PDGFRA—refractive error	0.00103	0.00109	CbGpPWpGaD
Afatinib—ERBB2—Integrated Pancreatic Cancer Pathway—PTEN—refractive error	0.00103	0.00109	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—WNT10A—refractive error	0.00102	0.00108	CbGpPWpGaD
Afatinib—EGFR—Signaling by EGFR—PDGFRA—refractive error	0.00102	0.00108	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—GREM2—refractive error	0.00101	0.00107	CbGpPWpGaD
Afatinib—ERBB2—B Cell Activation—PTEN—refractive error	0.00101	0.00107	CbGpPWpGaD
Afatinib—EGFR—Signaling by EGFR in Cancer—PDGFRA—refractive error	0.00101	0.00107	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—CTSC—refractive error	0.00101	0.00107	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—WNT10A—refractive error	0.00101	0.00107	CbGpPWpGaD
Afatinib—EGFR—Signaling by PDGF—PDGFRA—refractive error	0.00101	0.00107	CbGpPWpGaD
Afatinib—ERBB4—B Cell Activation—PTEN—refractive error	0.000996	0.00106	CbGpPWpGaD
Afatinib—LCK—Signaling by FGFR in disease—PDGFRA—refractive error	0.000991	0.00105	CbGpPWpGaD
Afatinib—LCK—Fc epsilon receptor (FCERI) signaling—PDGFRA—refractive error	0.000991	0.00105	CbGpPWpGaD
Afatinib—LCK—DAP12 interactions—PDGFRA—refractive error	0.000991	0.00105	CbGpPWpGaD
Afatinib—ABCB1—Allograft Rejection—PDGFRA—refractive error	0.00099	0.00105	CbGpPWpGaD
Afatinib—LCK—Signaling by EGFR—PDGFRA—refractive error	0.000983	0.00104	CbGpPWpGaD
Afatinib—BLK—Focal Adhesion—PTEN—refractive error	0.000978	0.00104	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways in Glioblastoma—PTEN—refractive error	0.000978	0.00104	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—VIPR2—refractive error	0.000975	0.00103	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—GREM2—refractive error	0.000975	0.00103	CbGpPWpGaD
Afatinib—LCK—Signaling by EGFR in Cancer—PDGFRA—refractive error	0.000974	0.00103	CbGpPWpGaD
Afatinib—EGFR—Focal Adhesion—PDGFRA—refractive error	0.000972	0.00103	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—CTSC—refractive error	0.00097	0.00103	CbGpPWpGaD
Afatinib—LCK—Signaling by PDGF—PDGFRA—refractive error	0.00097	0.00103	CbGpPWpGaD
Afatinib—EGFR—Integrated Pancreatic Cancer Pathway—PDGFRA—refractive error	0.000968	0.00103	CbGpPWpGaD
Afatinib—ERBB2—NGF signalling via TRKA from the plasma membrane—PTEN—refractive error	0.000968	0.00103	CbGpPWpGaD
Afatinib—ERBB2—Disease—RPS27—refractive error	0.000962	0.00102	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—RNF111—refractive error	0.000961	0.00102	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—TJP2—refractive error	0.000961	0.00102	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—CER1—refractive error	0.000961	0.00102	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—EBP—refractive error	0.00096	0.00102	CbGpPWpGaD
Afatinib—BLK—B Cell Activation—PTEN—refractive error	0.000958	0.00102	CbGpPWpGaD
Afatinib—ERBB4—NGF signalling via TRKA from the plasma membrane—PTEN—refractive error	0.000953	0.00101	CbGpPWpGaD
Afatinib—EGFR—B Cell Activation—PDGFRA—refractive error	0.000952	0.00101	CbGpPWpGaD
Afatinib—ERBB4—Disease—RPS27—refractive error	0.000947	0.00101	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—RNF111—refractive error	0.000946	0.001	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—CER1—refractive error	0.000946	0.001	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—TJP2—refractive error	0.000946	0.001	CbGpPWpGaD
Afatinib—EGFR—Constitutive PI3K/AKT Signaling in Cancer—PTEN—refractive error	0.000941	0.000998	CbGpPWpGaD
Afatinib—EGFR—Disease—DSE—refractive error	0.000931	0.000987	CbGpPWpGaD
Afatinib—LCK—B Cell Activation—PDGFRA—refractive error	0.000918	0.000974	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—RDH5—refractive error	0.000916	0.000972	CbGpPWpGaD
Afatinib—EGFR—Androgen receptor signaling pathway—PTEN—refractive error	0.000916	0.000971	CbGpPWpGaD
Afatinib—IRAK1—Immune System—CTSC—refractive error	0.000913	0.000969	CbGpPWpGaD
Afatinib—EGFR—NGF signalling via TRKA from the plasma membrane—PDGFRA—refractive error	0.000911	0.000967	CbGpPWpGaD
Afatinib—ABL1—DNA Damage Response (only ATM dependent)—PTEN—refractive error	0.000911	0.000967	CbGpPWpGaD
Afatinib—LCK—Constitutive PI3K/AKT Signaling in Cancer—PTEN—refractive error	0.000907	0.000962	CbGpPWpGaD
Afatinib—LCK—Disease—DSE—refractive error	0.000897	0.000952	CbGpPWpGaD
Afatinib—PHKG2—Disease—PDGFRA—refractive error	0.000897	0.000952	CbGpPWpGaD
Afatinib—LCK—NGF signalling via TRKA from the plasma membrane—PDGFRA—refractive error	0.000878	0.000932	CbGpPWpGaD
Afatinib—EGFR—Disease—RDH5—refractive error	0.000875	0.000928	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—AXL—refractive error	0.000869	0.000922	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CHN1—refractive error	0.00086	0.000912	CbGpPWpGaD
Afatinib—EGFR—PI-3K cascade—PTEN—refractive error	0.000848	0.000899	CbGpPWpGaD
Afatinib—LCK—Disease—RDH5—refractive error	0.000843	0.000895	CbGpPWpGaD
Afatinib—ABL1—Immune System—RNF111—refractive error	0.000841	0.000892	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—WNT10A—refractive error	0.000836	0.000887	CbGpPWpGaD
Afatinib—EGFR—Disease—PCCA—refractive error	0.00083	0.00088	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CHN1—refractive error	0.000829	0.000879	CbGpPWpGaD
Afatinib—EGFR—PI3K/AKT activation—PTEN—refractive error	0.000827	0.000878	CbGpPWpGaD
Afatinib—ERBB2—Innate Immune System—PDGFRA—refractive error	0.000827	0.000877	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—PAX6—refractive error	0.000826	0.000877	CbGpPWpGaD
Afatinib—EGFR—GAB1 signalosome—PTEN—refractive error	0.000821	0.000871	CbGpPWpGaD
Afatinib—ABCB1—Integrated Pancreatic Cancer Pathway—PML—refractive error	0.000821	0.000871	CbGpPWpGaD
Afatinib—LCK—PI-3K cascade—PTEN—refractive error	0.000817	0.000867	CbGpPWpGaD
Afatinib—ABL1—PDGFR-beta signaling pathway—PTEN—refractive error	0.000816	0.000866	CbGpPWpGaD
Afatinib—ERBB4—Innate Immune System—PDGFRA—refractive error	0.000814	0.000864	CbGpPWpGaD
Afatinib—ERBB2—Immune System—PML—refractive error	0.000809	0.000858	CbGpPWpGaD
Afatinib—EGFR—Role of LAT2/NTAL/LAB on calcium mobilization—PTEN—refractive error	0.000802	0.000851	CbGpPWpGaD
Afatinib—LCK—Disease—PCCA—refractive error	0.000799	0.000848	CbGpPWpGaD
Afatinib—LCK—PI3K/AKT activation—PTEN—refractive error	0.000797	0.000846	CbGpPWpGaD
Afatinib—ERBB4—Immune System—PML—refractive error	0.000797	0.000845	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—VANGL2—refractive error	0.000795	0.000843	CbGpPWpGaD
Afatinib—ERBB2—Adaptive Immune System—PDGFRA—refractive error	0.000794	0.000842	CbGpPWpGaD
Afatinib—LCK—GAB1 signalosome—PTEN—refractive error	0.000791	0.000839	CbGpPWpGaD
Afatinib—ERBB4—Adaptive Immune System—PDGFRA—refractive error	0.000782	0.00083	CbGpPWpGaD
Afatinib—LCK—Role of LAT2/NTAL/LAB on calcium mobilization—PTEN—refractive error	0.000773	0.00082	CbGpPWpGaD
Afatinib—BLK—Immune System—PML—refractive error	0.000766	0.000813	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—OR2M7—refractive error	0.000766	0.000813	CbGpPWpGaD
Afatinib—ABCG2—Transmembrane transport of small molecules—TUBB3—refractive error	0.000759	0.000805	CbGpPWpGaD
Afatinib—EGFR—Disease—IPO5—refractive error	0.000759	0.000805	CbGpPWpGaD
Afatinib—BLK—Adaptive Immune System—PDGFRA—refractive error	0.000752	0.000798	CbGpPWpGaD
Afatinib—ERBB2—Signaling by NGF—PTEN—refractive error	0.000744	0.00079	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—OR2M7—refractive error	0.000739	0.000784	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—WNT10A—refractive error	0.000739	0.000784	CbGpPWpGaD
Afatinib—ERBB4—Signaling by NGF—PTEN—refractive error	0.000733	0.000778	CbGpPWpGaD
Afatinib—LCK—Disease—IPO5—refractive error	0.000731	0.000776	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—COL9A1—refractive error	0.000728	0.000772	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—DSE—refractive error	0.000728	0.000772	CbGpPWpGaD
Afatinib—EGFR—Immune System—RNF111—refractive error	0.000718	0.000762	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—COL9A1—refractive error	0.000717	0.000761	CbGpPWpGaD
Afatinib—ABL1—Immune System—CTSC—refractive error	0.000715	0.000758	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—PAX6—refractive error	0.000706	0.000749	CbGpPWpGaD
Afatinib—EGFR—Disease—WNT10A—refractive error	0.000705	0.000748	CbGpPWpGaD
Afatinib—ABL1—Integrated Breast Cancer Pathway—PTEN—refractive error	0.000702	0.000745	CbGpPWpGaD
Afatinib—EGFR—Signaling by NGF—PDGFRA—refractive error	0.000701	0.000744	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—RNF111—refractive error	0.000694	0.000737	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—TJP2—refractive error	0.000694	0.000737	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—CER1—refractive error	0.000694	0.000737	CbGpPWpGaD
Afatinib—LCK—Immune System—RNF111—refractive error	0.000692	0.000734	CbGpPWpGaD
Afatinib—LCK—Disease—WNT10A—refractive error	0.00068	0.000721	CbGpPWpGaD
Afatinib—LCK—Signaling by NGF—PDGFRA—refractive error	0.000675	0.000717	CbGpPWpGaD
Afatinib—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—refractive error	0.000673	0.000714	CbGpPWpGaD
Afatinib—LCK—PDGFR-beta signaling pathway—PTEN—refractive error	0.000672	0.000713	CbGpPWpGaD
Afatinib—ABL1—EGF/EGFR Signaling Pathway—PTEN—refractive error	0.000664	0.000704	CbGpPWpGaD
Afatinib—EGFR—Disease—RNF111—refractive error	0.000663	0.000704	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—VIPR2—refractive error	0.000652	0.000691	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—PLA2G16—refractive error	0.000649	0.000688	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—PCCA—refractive error	0.000649	0.000688	CbGpPWpGaD
Afatinib—LCK—Disease—RNF111—refractive error	0.000639	0.000678	CbGpPWpGaD
Afatinib—EGFR—Direct p53 effectors—PTEN—refractive error	0.000637	0.000676	CbGpPWpGaD
Afatinib—EGFR—Signaling by SCF-KIT—PTEN—refractive error	0.000634	0.000672	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—VIPR2—refractive error	0.000628	0.000666	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—RDH5—refractive error	0.000613	0.00065	CbGpPWpGaD
Afatinib—EGFR—Immune System—CTSC—refractive error	0.000611	0.000648	CbGpPWpGaD
Afatinib—LCK—Signaling by SCF-KIT—PTEN—refractive error	0.000611	0.000648	CbGpPWpGaD
Afatinib—EGFR—Downstream signaling of activated FGFR—PTEN—refractive error	0.000606	0.000643	CbGpPWpGaD
Afatinib—EGFR—Integrated Breast Cancer Pathway—PTEN—refractive error	0.0006	0.000636	CbGpPWpGaD
Afatinib—IRAK1—Innate Immune System—PDGFRA—refractive error	0.000598	0.000634	CbGpPWpGaD
Afatinib—EGFR—Signaling by ERBB4—PTEN—refractive error	0.000597	0.000633	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—RDH5—refractive error	0.00059	0.000627	CbGpPWpGaD
Afatinib—LCK—Immune System—CTSC—refractive error	0.000589	0.000624	CbGpPWpGaD
Afatinib—IRAK1—Immune System—PML—refractive error	0.000585	0.000621	CbGpPWpGaD
Afatinib—LCK—Downstream signaling of activated FGFR—PTEN—refractive error	0.000584	0.00062	CbGpPWpGaD
Afatinib—ABL1—Integrated Pancreatic Cancer Pathway—PTEN—refractive error	0.000582	0.000617	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—AXL—refractive error	0.000581	0.000616	CbGpPWpGaD
Afatinib—LCK—Signaling by ERBB4—PTEN—refractive error	0.000575	0.00061	CbGpPWpGaD
Afatinib—EGFR—Disease—LUM—refractive error	0.000575	0.00061	CbGpPWpGaD
Afatinib—EGFR—Downstream signal transduction—PTEN—refractive error	0.00057	0.000605	CbGpPWpGaD
Afatinib—EGFR—Signaling by FGFR—PTEN—refractive error	0.000567	0.000602	CbGpPWpGaD
Afatinib—EGFR—EGF/EGFR Signaling Pathway—PTEN—refractive error	0.000567	0.000602	CbGpPWpGaD
Afatinib—EGFR—Signaling by ERBB2—PTEN—refractive error	0.000564	0.000599	CbGpPWpGaD
Afatinib—EGFR—DAP12 signaling—PTEN—refractive error	0.000561	0.000596	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—AXL—refractive error	0.00056	0.000594	CbGpPWpGaD
Afatinib—LCK—Disease—LUM—refractive error	0.000554	0.000588	CbGpPWpGaD
Afatinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—PTEN—refractive error	0.000553	0.000587	CbGpPWpGaD
Afatinib—LCK—Downstream signal transduction—PTEN—refractive error	0.000549	0.000583	CbGpPWpGaD
Afatinib—LCK—Signaling by FGFR—PTEN—refractive error	0.000546	0.00058	CbGpPWpGaD
Afatinib—LCK—Signaling by ERBB2—PTEN—refractive error	0.000544	0.000577	CbGpPWpGaD
Afatinib—LCK—DAP12 signaling—PTEN—refractive error	0.000541	0.000574	CbGpPWpGaD
Afatinib—IRAK1—Signaling by NGF—PTEN—refractive error	0.000538	0.000571	CbGpPWpGaD
Afatinib—LCK—Downstream signaling events of B Cell Receptor (BCR)—PTEN—refractive error	0.000533	0.000566	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—VANGL2—refractive error	0.000531	0.000564	CbGpPWpGaD
Afatinib—EGFR—Fc epsilon receptor (FCERI) signaling—PTEN—refractive error	0.000528	0.00056	CbGpPWpGaD
Afatinib—EGFR—DAP12 interactions—PTEN—refractive error	0.000528	0.00056	CbGpPWpGaD
Afatinib—EGFR—Signaling by FGFR in disease—PTEN—refractive error	0.000528	0.00056	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—COL9A1—refractive error	0.000526	0.000558	CbGpPWpGaD
Afatinib—EGFR—Signaling by EGFR—PTEN—refractive error	0.000523	0.000555	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—EBP—refractive error	0.000519	0.000551	CbGpPWpGaD
Afatinib—EGFR—Signaling by EGFR in Cancer—PTEN—refractive error	0.000519	0.000551	CbGpPWpGaD
Afatinib—EGFR—Signaling by PDGF—PTEN—refractive error	0.000517	0.000548	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—VANGL2—refractive error	0.000512	0.000543	CbGpPWpGaD
Afatinib—LCK—Signaling by FGFR in disease—PTEN—refractive error	0.000509	0.00054	CbGpPWpGaD
Afatinib—LCK—DAP12 interactions—PTEN—refractive error	0.000509	0.00054	CbGpPWpGaD
Afatinib—LCK—Fc epsilon receptor (FCERI) signaling—PTEN—refractive error	0.000509	0.00054	CbGpPWpGaD
Afatinib—LCK—Signaling by EGFR—PTEN—refractive error	0.000504	0.000535	CbGpPWpGaD
Afatinib—LCK—Signaling by EGFR in Cancer—PTEN—refractive error	0.0005	0.000531	CbGpPWpGaD
Afatinib—EGFR—Focal Adhesion—PTEN—refractive error	0.000499	0.00053	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—BMP2—refractive error	0.000499	0.000529	CbGpPWpGaD
Afatinib—LCK—Signaling by PDGF—PTEN—refractive error	0.000498	0.000528	CbGpPWpGaD
Afatinib—EGFR—Integrated Pancreatic Cancer Pathway—PTEN—refractive error	0.000497	0.000527	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—WNT10A—refractive error	0.000494	0.000524	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—BMP2—refractive error	0.000491	0.000521	CbGpPWpGaD
Afatinib—EGFR—B Cell Activation—PTEN—refractive error	0.000489	0.000519	CbGpPWpGaD
Afatinib—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—refractive error	0.000489	0.000518	CbGpPWpGaD
Afatinib—ERBB2—Immune System—PDGFRA—refractive error	0.000482	0.000511	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—WNT10A—refractive error	0.000476	0.000505	CbGpPWpGaD
Afatinib—ERBB4—Immune System—PDGFRA—refractive error	0.000474	0.000503	CbGpPWpGaD
Afatinib—LCK—B Cell Activation—PTEN—refractive error	0.000471	0.0005	CbGpPWpGaD
Afatinib—EGFR—NGF signalling via TRKA from the plasma membrane—PTEN—refractive error	0.000468	0.000496	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—PDGFRA—refractive error	0.000468	0.000496	CbGpPWpGaD
Afatinib—EGFR—Disease—RPS27—refractive error	0.000465	0.000493	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CER1—refractive error	0.000464	0.000493	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—TJP2—refractive error	0.000464	0.000493	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—RNF111—refractive error	0.000464	0.000493	CbGpPWpGaD
Afatinib—PHKG2—Disease—PTEN—refractive error	0.00046	0.000489	CbGpPWpGaD
Afatinib—ABL1—Immune System—PML—refractive error	0.000458	0.000486	CbGpPWpGaD
Afatinib—BLK—Immune System—PDGFRA—refractive error	0.000456	0.000484	CbGpPWpGaD
Afatinib—LCK—NGF signalling via TRKA from the plasma membrane—PTEN—refractive error	0.000451	0.000478	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—LUM—refractive error	0.00045	0.000477	CbGpPWpGaD
Afatinib—LCK—Disease—RPS27—refractive error	0.000448	0.000475	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—RNF111—refractive error	0.000448	0.000475	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CER1—refractive error	0.000448	0.000475	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—TJP2—refractive error	0.000448	0.000475	CbGpPWpGaD
Afatinib—ERBB2—Disease—PDGFRA—refractive error	0.000445	0.000472	CbGpPWpGaD
Afatinib—ERBB4—Disease—PDGFRA—refractive error	0.000438	0.000465	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—CACNA1D—refractive error	0.000433	0.000459	CbGpPWpGaD
Afatinib—ERBB2—Innate Immune System—PTEN—refractive error	0.000425	0.00045	CbGpPWpGaD
Afatinib—ERBB4—Innate Immune System—PTEN—refractive error	0.000418	0.000444	CbGpPWpGaD
Afatinib—ABCB1—Transmembrane transport of small molecules—TUBB3—refractive error	0.00041	0.000435	CbGpPWpGaD
Afatinib—ERBB2—Adaptive Immune System—PTEN—refractive error	0.000408	0.000433	CbGpPWpGaD
Afatinib—ERBB4—Adaptive Immune System—PTEN—refractive error	0.000402	0.000426	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—PDGFRA—refractive error	0.0004	0.000424	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—DSE—refractive error	0.000393	0.000417	CbGpPWpGaD
Afatinib—EGFR—Immune System—PML—refractive error	0.000391	0.000415	CbGpPWpGaD
Afatinib—BLK—Adaptive Immune System—PTEN—refractive error	0.000386	0.00041	CbGpPWpGaD
Afatinib—PHKG2—Metabolism—PTEN—refractive error	0.000386	0.000409	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—PDGFRA—refractive error	0.000385	0.000409	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—PDGFRA—refractive error	0.000384	0.000407	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—CYP26A1—refractive error	0.000382	0.000406	CbGpPWpGaD
Afatinib—LCK—Immune System—PML—refractive error	0.000377	0.0004	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—PDGFRA—refractive error	0.00037	0.000393	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—BMP2—refractive error	0.000361	0.000383	CbGpPWpGaD
Afatinib—EGFR—Signaling by NGF—PTEN—refractive error	0.00036	0.000382	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—COL9A1—refractive error	0.000352	0.000373	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—PLA2G16—refractive error	0.000351	0.000372	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—PCCA—refractive error	0.000351	0.000372	CbGpPWpGaD
Afatinib—IRAK1—Immune System—PDGFRA—refractive error	0.000348	0.000369	CbGpPWpGaD
Afatinib—LCK—Signaling by NGF—PTEN—refractive error	0.000347	0.000368	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—COL9A1—refractive error	0.000339	0.00036	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—PDGFRA—refractive error	0.000311	0.00033	CbGpPWpGaD
Afatinib—IRAK1—Innate Immune System—PTEN—refractive error	0.000307	0.000326	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—PDGFRA—refractive error	0.000307	0.000325	CbGpPWpGaD
Afatinib—ABL1—Immune System—PDGFRA—refractive error	0.000272	0.000289	CbGpPWpGaD
Afatinib—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—refractive error	0.000251	0.000266	CbGpPWpGaD
Afatinib—ERBB2—Immune System—PTEN—refractive error	0.000247	0.000262	CbGpPWpGaD
Afatinib—ERBB4—Immune System—PTEN—refractive error	0.000244	0.000258	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—LUM—refractive error	0.000243	0.000258	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—BMP2—refractive error	0.000241	0.000256	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—PTEN—refractive error	0.00024	0.000255	CbGpPWpGaD
Afatinib—BLK—Immune System—PTEN—refractive error	0.000234	0.000249	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—CACNA1D—refractive error	0.000234	0.000248	CbGpPWpGaD
Afatinib—EGFR—Immune System—PDGFRA—refractive error	0.000233	0.000247	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—BMP2—refractive error	0.000232	0.000247	CbGpPWpGaD
Afatinib—ERBB2—Disease—PTEN—refractive error	0.000228	0.000242	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—PDGFRA—refractive error	0.000225	0.000239	CbGpPWpGaD
Afatinib—ERBB4—Disease—PTEN—refractive error	0.000225	0.000239	CbGpPWpGaD
Afatinib—LCK—Immune System—PDGFRA—refractive error	0.000224	0.000238	CbGpPWpGaD
Afatinib—EGFR—Disease—PDGFRA—refractive error	0.000215	0.000228	CbGpPWpGaD
Afatinib—LCK—Disease—PDGFRA—refractive error	0.000207	0.00022	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—CYP26A1—refractive error	0.000207	0.000219	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—PTEN—refractive error	0.000205	0.000218	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—PTEN—refractive error	0.000198	0.00021	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—PTEN—refractive error	0.000197	0.000209	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—PTEN—refractive error	0.00019	0.000202	CbGpPWpGaD
Afatinib—IRAK1—Immune System—PTEN—refractive error	0.000179	0.00019	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—PTEN—refractive error	0.00016	0.00017	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—PTEN—refractive error	0.000157	0.000167	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—PDGFRA—refractive error	0.000151	0.00016	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—PDGFRA—refractive error	0.000145	0.000154	CbGpPWpGaD
Afatinib—ABL1—Immune System—PTEN—refractive error	0.00014	0.000148	CbGpPWpGaD
Afatinib—EGFR—Immune System—PTEN—refractive error	0.00012	0.000127	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—PTEN—refractive error	0.000116	0.000123	CbGpPWpGaD
Afatinib—LCK—Immune System—PTEN—refractive error	0.000115	0.000122	CbGpPWpGaD
Afatinib—EGFR—Disease—PTEN—refractive error	0.00011	0.000117	CbGpPWpGaD
Afatinib—LCK—Disease—PTEN—refractive error	0.000106	0.000113	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—PTEN—refractive error	8.63e-05	9.16e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—PTEN—refractive error	7.73e-05	8.2e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—PTEN—refractive error	7.45e-05	7.9e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—PTEN—refractive error	4.67e-05	4.95e-05	CbGpPWpGaD
